- $11.27m
- $7.34m
- $59.51m
- 34
- 48
- 46
- 38
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.5 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.19 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -211.56% | ||
| Return on Equity | -291.5% | ||
| Operating Margin | -26.29% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.11 | 8.98 | 33.4 | 76.07 | 59.51 | 59.7 | 64.42 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Flora Growth Corp. is a cannabis company that manufactures and distributes consumer packaged goods and distributes medicinal cannabis and pharmaceutical products. Its brand consists of JustCBD, Vessel, Melo, Haze, and Australian Vaporizers. JustCBD is a consumer-packaged goods brand with over 350 products, including cannabidiol gummies, topicals, tinctures, and vape products. JustCBD products are available for purchase in smoke and vape shops, clinics, spas, and pet stores, as well as other independent non-traditional retail channels. Vessel is the cannabis accessory and technology brand servicing the United States and Canada through direct-to-consumer and retail sales. Vessel's products include cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herb categories, which are sold to consumers, dispensaries, smoke shops, and cannabis brands. Australian Vaporizers is an online retailer of vaporizers, hardware, and accessories in Australia.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 13th, 2019
- Public Since
- May 11th, 2021
- No. of Shareholders
- 4,466
- No. of Employees
- 64
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 19,435,642
- Address
- 3230 W. Commercial Boulevard, Suite 180, FORT LAUDERDALE, 33309
- Web
- https://www.floragrowth.com/
- Phone
- +1 4168612267
- Auditors
- Davidson & Company LLP
Upcoming Events for FLGC
Similar to FLGC
ADVANCED BIOMED
NASDAQ Capital Market
IMEI Technology Health
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Astrana Health
NASDAQ Capital Market
Basel Medical
NASDAQ Capital Market
FAQ
What is the Flora Growth share price?
As of Today at 20:39 UTC, shares in Flora Growth are trading at $0.58. This share price information is delayed by 15 minutes.
How has the Flora Growth share price performed this year?
Shares in Flora Growth last closed at $0.58 and the price had moved by -62.34% over the past 365 days. In terms of relative price strength the Flora Growth share price has underperformed the S&P500 Index by -65.24% over the past year.
What are the analyst and broker recommendations for Flora Growth?
The overall consensus recommendation for Flora Growth is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Flora Growth dividend yield?
Flora Growth does not currently pay a dividend.
Does Flora Growth pay a dividend?
Flora Growth does not currently pay a dividend.
When does Flora Growth next pay dividends?
Flora Growth does not currently pay a dividend.
How do I buy Flora Growth shares?
To buy shares in Flora Growth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Flora Growth?
As of the previous close price of $0.58, shares in Flora Growth had a market capitalisation of $11.27m.
Where are Flora Growth shares listed?
Here are the trading details for Flora Growth:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: FLGC
What kind of share is Flora Growth?
Based on an overall assessment of its quality, value and momentum Flora Growth is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Flora Growth share price forecast for 2025?
The analyst consensus target price for shares in Flora Growth is $4.00. That is 589.66% above the last closing price of $0.58.
Analysts covering Flora Growth currently have a consensus Earnings Per Share (EPS) forecast of $0.07 for the next financial year.
Find out moreWhat is the trend in the Flora Growth share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Flora Growth. Over the past six months, its share price has underperformed the S&P500 Index by -66.96%.
As of the last closing price of $0.58, shares in Flora Growth were trading -45.99% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Flora Growth PE Ratio?
The Flora Growth PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.58.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Flora Growth?
We do not have data on Flora Growth's directors